Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 80 years of age
- People who have been diagnosed with Obstructive Sleep Apnea Hypopnea Syndrome (a condition where breathing repeatedly stops or becomes shallow during sleep), with a specific severity score of 5 or more events per hour
- People who are receiving a first-time diagnosis and have not previously had surgery or used a CPAP breathing machine for sleep apnea
- People who are willing and able to give written agreement to take part in the study
Who may not be able to join:
- People with a history of severe stroke or bleeding in the brain, or who have neurological or psychiatric conditions that could affect the study results
- People with active cancer, severe liver or kidney problems, diabetes, or significant blood vessel diseases
- People with severe chronic lung disease (COPD), severe asthma, severe high blood pressure in the lungs, or heart failure of any cause
- People who are pregnant or have any other condition that makes taking part in the study unsuitable (confirm with trial site)
- People who are considered extremely physically weakened or who have severe underlying health conditions (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Xanthine Oxidoreductase (XOR) Activity; Apnea-Hypopnea Index (AHI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.